For several years, Dr. Arthur Matas, director of the renal transplant program at the University of Minnesota's Department of Surgery, has been advocating for a fundamental shift in the country's kidney donation program. To address a significant and growing gap between the number of people waiting for a kidney transplant and the number of kidney donors, Matas, the immediate past president of the American Society of Transplant Surgeons, says we should create a system to compensate donors for kidneys on a trial basis. Why do we need a compensation program for kidney donors?
In 1980, if you went on the waiting list for a kidney, we could tell you that if you were a straightforward case, we would probably get you a transplant within a year. Now, I tell new patients that it's a five- or six-year wait. People who are acceptable candidates when they are put on the list are dying now before they can get a transplant. On average, more than 8 percent of people on the waiting list are dying. And in some parts of the country, there is close to a 10-year wait.
Doesn't paying people for donations seem a bit unseemly?
People are concerned that if there is compensation you'll hurt the dignity of the person who is the compensated donor as opposed to the person who is the altruistic donor. I don't believe that. I think if you create a culture of dignity around the whole process, we'll be fine. We have paid heroes in our society -- policemen, firemen, soldiers, etc. Donors can be compensated heroes just as well.
So how would a compensation system work?
First, you have to change the law. Second, you have to decide the context of a trial. Would you do it regionally and only allow parts of the country to do it, or would this be something overall in the country? We currently have an allocation system for deceased donors that runs through an organ-procurement organization, which in our area is LifeSource, so you could run this trial through organ-procurement organizations like LifeSource.
This is a hypothetical model and anyone could come up and tweak the details, but a potential compensated donor would call up LifeSource and you would have a screening interview. If they passed that, they would undergo a full evaluation as organized. And then have a panel at LifeSource consisting of, say, a surgeon, nephrologist, social worker, donor advocate, etc., who would review the overall evaluation, and we would have national criteria, and they would approve or disapprove the potential donor. Then run the list the same way that we would do for a deceased donor.
So what kind of evaluation would you need for this?